VALENT GL CORPORATION – Trademark Portfolio
Entity Type: 03
VALENT GL CORPORATION holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 15 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include GREEN LIGHT and SUPER BLOOM. The owner is based in WALNUT CREEK, CA.
1600 RIVIERA AVENUE, SUITE 200
WALNUT CREEK, CA 945968025
Showing of trademarks Trademarks
Trademark Classifications
VALENT GL CORPORATION's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does VALENT GL CORPORATION have?
VALENT GL CORPORATION has 19 U.S. trademarks filed with the USPTO. Of these, 4 registered, 15 cancelled.
What trademark classes does VALENT GL CORPORATION file in?
VALENT GL CORPORATION files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are VALENT GL CORPORATION's most well-known trademarks?
VALENT GL CORPORATION's registered trademark portfolio includes well-known marks such as GREEN LIGHT and SUPER BLOOM. These are among 4 currently registered trademarks in the portfolio.
What is VALENT GL CORPORATION's trademark registration success rate?
VALENT GL CORPORATION has a 21% trademark registration rate, with 4 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.